Related Experiment Videos
Endometrial ablation with a new thermal balloon system
Prashant S Mangeshikar1, Anupam Kapur, Douglass B Yackel
1Center for Gynecological Endoscopic Surgery, Mumbai, India.
Summary
The Thermablate EAS endometrial ablation device effectively treated menorrhagia in women. Most patients experienced amenorrhea or hypomenorrhea with no complications, indicating its promise for gynecological procedures.
Area of Science:
- Gynecology
- Minimally Invasive Surgery
Background:
- Menorrhagia is a common gynecological condition impacting women's quality of life.
- Endometrial ablation offers a treatment option for heavy menstrual bleeding.
Purpose of the Study:
- To evaluate the effectiveness of the Thermablate EAS, a novel endometrial ablation instrument, for treating menorrhagia.
Main Methods:
- Retrospective observational study (Canadian Task Force classification II-1).
- Study conducted in urban hospital and private clinic settings in Bombay, India.
- Involved sixteen women diagnosed with menorrhagia.
Main Results:
- At 6-month follow-up, 50% of patients achieved amenorrhea (no periods) and 38% experienced hypomenorrhea (lighter periods).
- One case of cystic hyperplasia was the only treatment failure.
- No adverse complications were reported during the study period.
Conclusions:
- The Thermablate EAS demonstrates potential as an effective and safe instrument for endometrial ablation.
- This device offers a promising minimally invasive approach for managing menorrhagia.